- 1301. Carrier or suspected carrier of viral hepatitis
- [ ] (UMLS (ICD9CM) C0543428) =Finding
| - 1351. case management
- [A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. (From Slee & Slee, Health Care Terms, 2nd ed) ( MSH )] (UMLS (CSP) C0085971) =Health Care Activity
|
- 1302. Carrier Protein
- [diverse group of proteins which serve as carriers of ligands through solubility barriers such as aqueous body fluids (for lipoid hormones) or lipid membranes (for inorganic ions). ( CSP )] (UMLS (NCI) C0007292) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=gene product;
=fatty acid binding protein;
Chaperone;
hormone binding globulin;
membrane transport protein;
| - 1352. Case Management
- (UMLS (HL7) C1552408) =Health Care Related Organization =Agencies;
|
- 1303. carrier state (disease)
- [condition of harboring an infective organism without manifesting symptoms of infection; organism is readily transmissable to another susceptible host. ( CSP )] (UMLS (CSP) C0560175) =Finding =communicable disease transmission;
| - 1353. Case Management
- (UMLS (HL7) C1555968) =Professional or Occupational Group =Registered Nurse;
|
- 1304. Carrier type
- (UMLS (HL7) C1547770) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 1354. case report
- [A detailed report of the diagnosis, treatment, and follow-up of an individual patient. Case reports also contain some demographic information about the patient (for example, age, gender, ethnic origin). ( NCI )] (UMLS (NCI) C0085973) =Intellectual Product
|
- 1305. carrot mottle virus
- [ ] (UMLS (CSP) C0318795) =Virus
| - 1355. case series
- [A group or series of case reports involving patients who were given similar treatment. Reports of case series usually contain detailed information about the individual patients. This includes demographic information (for example, age, gender, ethnic origin) and information on diagnosis, treatment, response to treatment, and follow-up after treatment. ( NCI )] (UMLS (NCI) C0150093) =Research Activity
|
- 1306. carry forward adjusment
- [An amount still owing to the payor but the payment is 0$ and this cannot be settled until a future payment is made. ( HL7V3.0 )] (UMLS (HL7) C1555695) =Intellectual Product =ActInvoiceAdjudicationPaymentGroupCode;
| - 1356. Case Subject
- [A person, non-person living subject, or place that is the subject of an investigation related to a notifiable condition (health circumstance that is reportable within the applicable public health jurisdiction) ( HL7V3.0 )] (UMLS (HL7) C1698493) =Idea or Concept =Investigation Subject;
|
- 1307. Carson's Modified 10% formalin
- (UMLS (HL7) C1550058) =Organic Chemical; Biomedical or Dental Material ;
=Additive/Preservative;
| - 1357. casein
- [principle protein of milk, whose precipitation by calcium is the basis of curdling; used as a nutritional supplement. ( CSP )] (UMLS (CSP) C0007332) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Milk Proteins;
Phosphoprotein;
Inactive Ingredient Preparations;
=SODIUM CASEINATE;
CRITICARE HN LIQUID;
LONALAC POWDER,ORAL |
- 1308. Carson's Modified 10% formalin
- [A modification of buffered 10% formalin used as a general tissue preservative. ( HL7V3.0 )] (UMLS (HL7) C1561460) =Intellectual Product =MaterialEntityAdditive;
| - 1358. casein kinase
- [nonEC; a ubiquitous group of protein serine/threonine kinases involved in many cellular functions, assayed by their ability to phosphorylate casein in vitro. ( CSP )] (UMLS (CSP) C0054846) =Amino Acid, Peptide, or Protein; Enzyme =alcohol phosphotransferase;
|
- 1309. Cart - patient travels on cart or gurney
- (UMLS (HL7) C1548299) =Idea or Concept =Transportation Mode;
| - 1359. Casein Kinase 1, Alpha 1
- [Casein Kinase 1, Alpha 1, encoded by the human CSNK1A1 gene, is a serine/threonine protein kinase and has broad specificity. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. This cytoplasmic protein can phosphorylate a large number of proteins. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C1332857) Casein Kinase I, Alpha Isoform;
CKI-Alpha;
CSNK1A1;
Down-Regulated In Lung Cancer =Amino Acid, Peptide, or Protein; Enzyme |
- 1310. CARTD BODY/SINUS/VASC OP
- [ ] (UMLS (ICD9CM) C0176693) =Therapeutic or Preventive Procedure
| - 1360. Casein Kinase 1, Alpha 1 Gene
- [This gene plays a role in signal transduction and intercellular communication. ( NCI )] (UMLS (NCI) C1332795) CSNK1A1;
CSNK1A1 Gene =Gene or Genome |
- 1311. CARTEOLOL
- [A synthetic quinolinone derivative and nonselective beta-adrenoceptor blocking agent with anti-glaucoma activity. Upon topical administration to the eye, carteolol decreases aqueous humor production, thereby reducing intraocular pressure (IOP). ( NCI )] (UMLS (NCI) C0007299) =Organic Chemical; Pharmacologic Substance ;
=Propanolamines;
[CV100] BETA-BLOCKERS/RELATED =CARTEOLOL HYDROCHLORIDE;
CARTEOLOL 2.5 MG;
CARTEOLOL 5 MG | - 1361. Casein Kinase 2, Alpha 1 Polypeptide
- [Casein Kinase 2, Alpha 1 Polypeptide is encoded by the CSNK2A1 gene. Casein kinase II is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. This kinase exists as a tetramer and is composed of an alpha, an alpha-prime, and two beta subunits. The alpha subunits contain the catalytic activity while the beta subunits undergo autophosphorylation. Three transcript variants encoding two different isoforms have been found for this gene. (From LocusLink) ( NCI )] (UMLS (NCI) C1332856) casein kinase II alpha 1 subunit;
Casein kinase II, alpha chain;
Casein Kinase II, Alpha Subunit;
Casein Kinase II, Alpha-1;
CK II;
CK2 catalytic subunit alpha;
CSNK2A1;
EC 2.7.1.37 =Amino Acid, Peptide, or Protein; Enzyme |
- 1312. cartilage
- [nonvascular form of connective tissue composed of chondrocytes embedded in a matrix of type II collagen and chondroitin sulfate; divided into three types: hyaline cartilage, fibrocartilage, and yellow or elastic white fibrocartilage. ( CSP )] (UMLS (CSP) C0007301) =Tissue =connective tissue;
skeletal =articular cartilage;
Intervertebral Disc;
| - 1362. Casein Kinase 2, Alpha Prime Polypeptide Gene
- [This gene is involved in DNA repair, intercellular communication and signal transduction. ( NCI )] (UMLS (NCI) C1332796) CSNK2A1;
CSNK2A1 Gene =Gene or Genome |
- 1313. cartilage cancer
- [new abnormal cartilage that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease. ( CSP )] (UMLS (CSP) C0476147) =Neoplastic Process =connective tissue cancer;
skeletal neoplasm | - 1363. CaseSeriousnessCriteria
- [A code that provides information on the overall effect or outcome of the adverse reaction/adverse event reported in the ICSR. Note the criterion applies to the case as a whole and not to an individual reaction. Example concepts are: death, disability, hospitalization, congenital anomaly/ birth defect, and other medically important condition. ( HL7V3.0 )] (UMLS (HL7) C1699002) =Qualitative Concept =Individual Case Safety Report Value Domains;
|
- 1314. cartilage cell
- [ ] (UMLS (CSP) C0225367) =Cell
| - 1364. Cash
- (UMLS (HL7) C1619834) =Intellectual Product ;
=ActAccountCode;
|
- 1315. cartilage circulation
- [ ] (UMLS (CSP) C0599421) =Organ or Tissue Function
| - 1365. Cash on Delivery
- [Payment in full for products and/or services is required as soon as the service is performed or goods delivered. ( HL7V3.0 )] (UMLS (HL7) C1555037) =Functional Concept =PaymentTerms;
|
- 1316. cartilage development
- [formation and growth of cartilage; the process is directed by chondrocytes which continually divide and lay down matrix during development; it is sometimes a precursor to osteogenesis. ( CSP )] (UMLS (CSP) C0598067) =Organ or Tissue Function ;
=connective tissue development;
| - 1366. CASP1
- [Caspase-1, encoded by the CASP1 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. This gene was identified by its ability to proteolytically cleave and activate the inactive precursor of interleukin-1, a cytokine involved in the processes such as inflammation, septic shock, and wound healing. This gene has been shown to induce cell apoptosis and may function in various developmental stages. Studies of the similar gene in mouse suggested its role in the pathogenesis of Huntington disease. Alternative splicing of this gene results in five transcript variants encoding distinct isoforms. (From LocusLink) ( NCI )] (UMLS (NCI) C0534519) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1317. Cartilage Development Disorder
- [morbid condition characterized by abnormal development of cartilage. ( CSP )] (UMLS (NCI) C0008449) =Disease or Syndrome =bone development disorder;
Cartilage Diseases;
congenital skeletal disorder;
| - 1367. CASP1
- [This gene plays a role in apoptosis, inflammation, septic shock, and wound healing. ( NCI )] (UMLS (NCI) C1366479) CASP1 Gene;
Caspase 1, Apoptosis-Related Cysteine Protease Gene;
=Gene or Genome ;
|
- 1318. cartilage disorder therapy
- [ ] (UMLS (CSP) C0872127) =Therapeutic or Preventive Procedure
| - 1368. CASP10
- [This gene is involved in the activation of apoptosis. ( NCI )] (UMLS (NCI) C1332661) CASP10 Gene;
Caspase 10, Apoptosis-Related Cysteine Protease Gene =Gene or Genome ;
|
- 1319. Cartilage Hair Hypoplasia
- (UMLS (NCI) C0220748) =Congenital Abnormality; Disease or Syndrome
| - 1369. CASP2
- [This gene is involved in either the promotion or inhibition of apoptosis depending on both the cell lineage and stage of development. ( NCI )] (UMLS (NCI) C1332662) CASP2 Gene;
Caspase 2, Apoptosis-Related Cysteine Protease Gene =Gene or Genome ;
|
- 1320. Cartilage Injury
- (UMLS (NCI) C0852694) =Injury or Poisoning
| - 1370. CASP2
- [Caspase-2, encoded by the CASP2 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspase-2 is synthesized as an inactive proenzyme which is activated by an alternative CD 95 pathway which involves the formation of a complex between oligomerized CD 95 and the accessory proteins RIP and RAIDD. After activation, caspase 2 induces apoptosis by triggering the caspase cascade. The proteolytic cleavage of this caspase is induced by a variety of apoptotic stimuli. In contrast to caspase 8, caspase 2 contains no death effector domain. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C1453171) CASP-2;
Caspase 2, Apoptosis-Related Cysteine Protease;
Caspase 2, Apoptosis-Related Cysteine Protease (Neural Precursor Cell Expressed, Developmentally Down-Regulated 2);
Caspase-2;
EC 3.4.22.-;
ICH1;
ICH-1;
ICH-1 Protease;
ICH-1L;
ICH-1L/1S;
NEDD2;
NEDD2 Apoptosis Regulatory Protein;
Neural Precursor Cell Expressed, Developmentally Downregulated 2;
=Amino Acid, Peptide, or Protein; Enzyme |
- 1321. Cartilage Matrix
- (UMLS (NCI) C0225371) =Tissue
| - 1371. CASP3
- [This gene plays a role in the execution phase of apoptosis and is involved in DNA repair. ( NCI )] (UMLS (NCI) C1413132) CASP3 Gene;
Caspase 3, Apoptosis-Related Cysteine Peptidase Gene =Gene or Genome |
- 1322. cartilage metabolism
- [sum of chemical changes that occur within the cartilage of an organism consisting of anabolism (biosynthesis) and catabolism; the buildup and breakdown of molecules for utilization by the cartilage. ( CSP )] (UMLS (CSP) C0596276) =Organ or Tissue Function ;
=connective tissue metabolism;
| - 1372. CASP4
- [This gene is involved in the promotion of apoptosis. ( NCI )] (UMLS (NCI) C1366513) CASP4 Gene;
Caspase 4, Apoptosis-Related Cysteine Protease Gene =Gene or Genome |
- 1323. cartilage transplantation
- [transference of cartilage within an individual, between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596278) =Therapeutic or Preventive Procedure ;
=musculoskeletal transplantation;
| - 1373. CASP5
- [Caspase-5, encoded by the CASP5 Gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Overexpression of the active form of this enzyme has been shown to induce apoptosis in fibroblasts. Max, a central component of the Myc/Max/Mad transcription regulation network important for cell growth, differentiation, and apoptosis, is cleaved by this protein, which required Fas-mediated dephosphorylation of Max. The expression of this gene is regulated by interferon-gamma and lipopolysaccharide. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0769345) CASP5 Protein;
Caspase 5, Apoptosis-Related Cysteine Protease;
Caspase-5;
Cysteine Protease;
EC 3.4.22.-;
ICE(rel)-III;
ICH3;
ICH-3 Protease;
TY Protease;
=Amino Acid, Peptide, or Protein; Enzyme ;
|
- 1324. Cartilage-Inducing Factor-B
- [TGF-beta 2, encoded by the TGFB2 gene, is a disulfide-linked homodimer belonging to the TGF-beta cytokine family that has suppressive effects on Interleukin-2-dependent T-cell growth. It may have an autocrine function in enhancing tumor growth and/or reducing immunosurveillance of tumor development. Two isoforms are produced by alternative splicing. TGF-beta 2 is expressed in a wide variety of mesenchymal tissues and in the ventral nervous system during human embryogenesis. (from OMIM 190220, Swiss-Prot P08112, and NCI) ( NCI )] (UMLS (NCI) C0079441) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1374. CASP5
- [This gene plays a role in apoptosis, cell growth and differentiation. ( NCI )] (UMLS (NCI) C1332664) CASP5 Gene;
Caspase 5, Apoptosis-Related Gene =Gene or Genome |
- 1325. Cartilagenous Hamartoma
- (UMLS (NCI) C0334087) =Neoplastic Process
| - 1375. CASP6
- [This gene is involved in the execution of apoptosis. ( NCI )] (UMLS (NCI) C1332665) CASP6 Gene;
CASPASE 6, Apoptosis-Related Cysteine Protease Gene =Gene or Genome |
- 1326. Cartilagenous Metaplasia
- (UMLS (NCI) C0334042) =Pathologic Function
| - 1376. CASP7
- [This gene plays a role in the execution phase of apoptosis and is also involved in the regulation of lipogenic and cholesterogenic gene transcription. ( NCI )] (UMLS (NCI) C1332666) CASP7 Gene;
Caspase 7, Apoptosis-Related Cysteine Protease Gene =Gene or Genome |
- 1327. cartilaginous fishes
- [fish with lateral fins, gills in separate gill clefts, skin covered with placoid scales, cartilaginous skeleton, no bone present and spriacles connecting to pharynx; most are marine. ( CSP )] (UMLS (CSP) C0327606) =Fish =fish;
=shark;
Torpedo;
| - 1377. CASP8
- [A member of the ICE cysteine-protease family. A downstream factor in apoptosis induced by TNFR and FAS ( NCI )] (UMLS (NCI) C0667830) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 1328. CARTON
- [A cardboard box or container which is usually considered a secondary packaging component. ( NCI )] (UMLS (NCI) C1361561) CRTN;
MISCELLANEOUS MEDICAL SUPPLY CARTON =Medical Device | - 1378. CASP8
- [This gene is involved in apoptosis, immune cell homeostasis, lymphocyte activation and immunoprotection. ( NCI )] (UMLS (NCI) C1332667) CASP8 Gene;
Caspase 8, Apoptosis-Related Cysteine Protease Gene =Gene or Genome |
- 1329. Cartridge
- [A sealed container of liquid or powder intended to be loaded into a device. ( HL7V3.0 )] (UMLS (HL7) C1553461) =Intellectual Product =MultiUseContainerEntityType;
| - 1379. CASP9
- [This gene plays a role in the initiation of the apoptotic cascade. ( NCI )] (UMLS (NCI) C1332668) CASP9 Gene;
Caspase 9, Apoptosis-Related Cysteine Protease Gene =Gene or Genome |
- 1330. CARTRIDGE
- [A container consisting of a cylinder with a septum at one end, and a seal at the other end, which is inserted into a device to form a syringe which contains a single dose of a parenteral drug product. ( NCI )] (UMLS (NCI) C0179630) =Medical Device
| - 1380. caspase
- [The caspases are a family of proteases responsible for carrying out the cell death process. In a living cell, these proteases are kept inactive by proteins on the mitochondrial cell surface from the BcL-2 family. When a cell is exposed to cell death signals such as ischemia, chemotherapy or radiation, BcL-2 function is blocked and caspase activators initiate the cell death cascade. ( NCI )] (UMLS (CSP) C0010656) =Amino Acid, Peptide, or Protein; Enzyme ;
=Endopeptidase;
=calpain;
papain;
Amyloid Precursor Protein Secretase |
- 1331. Carubicin hydrochloride
- [Hydrochloride salt of the anthracycline antineoplastic antibiotic carubicin. Carubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0282089) =Organic Chemical; Pharmacologic Substance ;
| - 1381. Caspase Activation
- [Caspase Activation involves induction of the activity of intracellular cysteine endopeptidase family members kept inactive by mitochondrial surface proteins (BcL-2 Family) and involved in initial signaling and downstream proteolytic cleavages (at P1 aspartic acids) in inflammation and apoptotic cell death when signals block BcL-2 function and activators initiate caspase cascades. ( NCI )] (UMLS (NCI) C1159825) =Molecular Function
|
- 1332. CARVEDILOL
- [A synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta-adrenoceptor blocking agent (S(-) enantiomer) and as an alpha 1-adrenoceptor blocker (R(+) and S(-) enantiomers). Its acts more strongly on beta-receptors than on alpha 1-receptors, reduces peripheral vascular resistance by vasodilation, and prevents reflex tachycardia (beta-blockade) so that heart rate is either unchanged or decreased. Carvedilol also reduces renin release through beta-blockade. (NCI04) ( NCI )] (UMLS (NCI) C0054836) =Organic Chemical; Pharmacologic Substance =Carbazoles;
Propanolamines;
[CV100] BETA-BLOCKERS/RELATED;
=CARVEDILOL 12.5 MG;
CARVEDILOL 25 MG;
CARVEDILOL 6.25 MG;
CARVEDILOL 3.125 MG | - 1382. Caspase Gene
- [These genes encode caspases, a family of intracellular cysteine proteinases involved in inflammation and apoptosis. These enzymes appear to be involved in the initial signaling events, as well as the downstream proteolytic cleavages, that result in apoptotic cell death. They are specific for aspartic acid at the P1 position and are divided into two classes based on the lengths of their N-terminal pro-domains. Caspases-1, -2, -4, -5, -8, and -10 have long pro-domains while caspases-3, -6, -7, and -9 have short pro-domains. (from Science 1998. 281:1312 and Br Med Bull 1997. 53:478) ( NCI )] (UMLS (NCI) C1332858) =Gene or Genome ;
|
- 1333. Cary Blair Medium
- (UMLS (HL7) C1550059) =Organic Chemical; Biomedical or Dental Material ;
=Additive/Preservative;
| - 1383. Caspofungin Acetate
- [A drug used to prevent or treat infections caused by a fungus (a type of microorganism). It belongs to the family of drugs called antifungal agents. ( NCI )] (UMLS (NCI) C0935942) CASPOFUNGIN ACETATE PREPARATION;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=CASPOFUNGIN;
=CASPOFUNGIN ACETATE 50 MG;
CASPOFUNGIN ACETATE 70 MG |
- 1334. Cary Blair Medium
- [Sodium Thioglycollate 1.5 g, Disodium Hydrogen Phosphate 1.1 g, Sodium Chloride 5.0 g, Calcium Chloride 0.09 g, Agar 5.0 g, per Liter of Water ( HL7V3.0 )] (UMLS (HL7) C1561463) =Intellectual Product =MaterialEntityAdditive;
| - 1384. cassette mutagenesis
- [ ] (UMLS (CSP) C0079867) =Molecular Biology Research Technique
|
- 1335. Caryolysine
- (UMLS (NCI) C0007310) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 1385. CASSIA OIL
- (UMLS (NCI) C0301249) =Lipid; Pharmacologic Substance =CASSIA OIL;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=CASSIA OIL;
ALKALOL SOLUTION;
AVALGESTIC ANALGESIC LOTION;
CINNAMON OIL 5.4 %;
|
- 1336. CAS W CT/CTA
- [ ] (UMLS (ICD9CM) C1456026) Computer assisted surgery with CT/CTA;
=Therapeutic or Preventive Procedure | - 1386. Cassia yellow blotch virus
- [ ] (UMLS (CSP) C0598036) =Virus ;
|
- 1337. CAS W FLUOROSCOPY
- [ ] (UMLS (ICD9CM) C1456028) Computer assisted surgery with fluoroscopy;
=Therapeutic or Preventive Procedure | - 1387. Cast Formation
- (UMLS (NCI) C1332859) =Finding ;
|
- 1338. CAS W MR/MRA
- [ ] (UMLS (ICD9CM) C1456027) Computer assisted surgery with MR/MRA;
=Therapeutic or Preventive Procedure | - 1388. castanospermine
- [1,6,7,8-tetrahydroxy octahydroindolizine; an inhibitor of glucosylceramidase used to block certain protein glycosylations. ( CSP )] (UMLS (CSP) C0054849) =Organic Chemical; Pharmacologic Substance =alkaloid;
[AM800] ANTIVIRALS |
- 1339. CAS W MULTIPLE DATASETS
- [ ] (UMLS (ICD9CM) C1456030) Computer assisted surgery with multiple datasets;
=Therapeutic or Preventive Procedure | - 1389. Castillian
- (UMLS (HL7) C1553361) =Population Group =Spaniard;
|
- 1340. Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence B Gene
- [This gene plays a role in the regulation of T cell activation. ( NCI )] (UMLS (NCI) C1332672) CBLB;
CBLB Gene =Gene or Genome | - 1390. castor bean tick
- [ ] (UMLS (CSP) C0282509) =Invertebrate
|
- 1341. Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence Gene
- [This gene plays a role in signal transduction and the regulation of protein degradation. ( NCI )] (UMLS (NCI) C0812242) CBL;
CBL Gene =Gene or Genome | - 1391. Castrated Female
- [A female individual who has had her ovaries removed. ( NCI )] (UMLS (NCI) C1319066) Spayed Female;
=Finding ;
|
- 1342. Casanthranol/Docusate
- [A combination of laxatives, Casanthranol Docusate is used in constipation and various medical conditions. Casanthranol is a concentrated mixture of anthranol glycosides from cascara sagrada (dried bark of Rhamnus p.) and a stimulant laxative that encourages bowel movements by acting on the intestinal wall to increase muscle contractions. A surface-active emollient, stool softener Docusate helps liquids to mix into dry stool, allowing patients to have a bowel movement without straining. (NCI04) ( NCI )] (UMLS (NCI) C0717564) =Organic Chemical; Pharmacologic Substance ;
| - 1392. Castrated Male
- [A male individual who has had his testicles removed. ( NCI )] (UMLS (NCI) C1319065) Neutered Male;
=Finding ;
|
- 1343. CASC3
- [Encoded by human MLN51 Gene, ubiquitous cytoplasmic 76.3 kD MLN51 Protein contains 703 residues that share no significant homology with any known protein. MLN51 is well conserved between vertebrate and invertebrate species suggesting an important function. The N-terminal half contains putative nuclear localization signals and a coiled-coil domain that seems to promote MLN51 oligomerization. The C-terminal half contains a SH2 and four SH3 binding motifs and may regulate nuclear localization. The unusual combination of protein-protein interaction domains in MLN51 suggests a possible nucleo-cytoplasmic function. Malignant breast carcinoma epithelial cells exhibit over expression of MLN51. (from Oncogene 2002; 21:4422, SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1137611) Metastatic Lymph Node 51 Protein;
MLN51;
MLN51 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1393. castration
- [Removal or destruction of the testicles or ovaries using radiation, surgery, or drugs. Medical castration refers to the use of drugs to suppress the function of the ovaries or testicles. ( NCI )] (UMLS (CSP) C0007344) =Therapeutic or Preventive Procedure
|
- 1344. Cascades-Wasco-Wishram
- (UMLS (HL7) C1551921) Kiksht;
=Language =UpperChinook;
| - 1394. Castration
- [(or-kee-EK-toe-mee) Surgery to remove one or both testicles. ( NCI )] (UMLS (NCI) C0029189) =Therapeutic or Preventive Procedure ;
|
- 1345. Cascara
- [Used as a laxative in constipation and various medical conditions, Cascara (cascara sagrada) is dried bark of Picramnia sp. (Simarubaceae) or Rhamnus purshiana (Rhamnaceae) containing stimulant laxative anthranol glycosides that act on the intestinal wall to increase muscle contractions and encourage bowel movements. (NCI04) ( NCI )] (UMLS (NCI) C0205704) =Organic Chemical; Pharmacologic Substance =Anthracenedione;
Cascara;
[GA204] STIMULANT LAXATIVES;
Inactive Ingredient Preparations =1,3,8-Trihydroxy-6-methylanthraquinone;
Cascara;
CASANTHRANOL;
Cascara;
CASCARA SAGRADA EXTRACT 60 MG;
CASCARA SAGRADA EXTRACT 222 MG/5ML;
Cascara;
Cascara sagrada 5 ML Oral Solution;
CASCARA/MAGNESIUM HYDROXIDE CONC SUSP;
CASCARA SAGRADA 1 GM/ML;
CASCARA SAGRADA 150 MG;
CASCARA SAGRADA 325 MG;
CASCARA SAGRADA 450 MG;
CASCARA SAGRADA 60 MG | - 1395. cat
- [refers to all members of the cat family, from the breeds of domestic cats through the great cats. ( CSP )] (UMLS (CSP) C0325089) =Mammal =Carnivora;
|
- 1346. Case Category Code
- (UMLS (HL7) C1547804) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Doctor_s Office Closed | - 1396. Cat
- [The domestic cat, Felis catus. ( NCI )] (UMLS (NCI) C0007450) =Mammal ;
|
- 1347. case control
- [ ] (UMLS (CSP) C0872128) =Health Care Activity
| - 1397. cat
- [bacterial enzyme which detoxifies the antibiotic chloramphenicol the gene therefore confers chloramphenicol resistance, which can be used as a marker or selector in genetic transfection experiments. ( CSP )] (UMLS (NCI) C0008169) =Amino Acid, Peptide, or Protein; Enzyme ;
=Acetyltransferase;
Genes, Reporter |
- 1348. case control study
- [Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group. ( MSH )] (UMLS (CSP) C0007328) =Research Activity
| - 1398. CAT
- [radiography in which a three dimensional image of a body structure is constructed by computer from a series of plane cross sectional images made along an axis. ( CSP )] (UMLS (NCI) C0040405) =Diagnostic Procedure =Tomography;
Modality;
ObservationMethod;
|
- 1349. case finding
- [ ] (UMLS (CSP) C0681690) =Occupational Activity ;
| - 1399. cat
- [Bacterial chloramphenicol-O-acetyltransferase (cat) gene encodes chloramphenicol-O-acetyltransferase protein, an enzyme that acetylates the antiobiotic chloramphenicol to yield chloramphenicol 3-acetate. This product is not an inhibitor of peptidyltransferase, the enzyme responsible for natural chloramphenicol resistance in bacteria. The cat gene is used to select chloramphenicol-resistant colonies following genetic transfection of bacteria. ( NCI )] (UMLS (NCI) C1366498) cat Gene;
Chloramphenicol Acetyl Transferase Gene =Gene or Genome |
- 1350. case history
- [collected data concerning an individual, including family, environment, medical history and any other information that may be useful in analysis and diagnois of medical condition. ( CSP )] (UMLS (CSP) C0085970) =Intellectual Product =medical record;
| - 1400. CAT
- [This gene plays a role in both the catabolism of reactive oxygen species and detoxification of hydrogen peroxide. ( NCI )] (UMLS (NCI) C1413138) CAT Gene;
Catalase Gene =Gene or Genome |
home
